JP2022530192A5 - - Google Patents
Info
- Publication number
- JP2022530192A5 JP2022530192A5 JP2021560095A JP2021560095A JP2022530192A5 JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5 JP 2021560095 A JP2021560095 A JP 2021560095A JP 2021560095 A JP2021560095 A JP 2021560095A JP 2022530192 A5 JP2022530192 A5 JP 2022530192A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1905263.8 | 2019-04-12 | ||
| EP19169121.1 | 2019-04-12 | ||
| GBGB1905263.8A GB201905263D0 (en) | 2019-04-12 | 2019-04-12 | Plasmid system |
| EP19169121.1A EP3722434B1 (en) | 2019-04-12 | 2019-04-12 | Plasmid system |
| PCT/GB2020/050947 WO2020208379A1 (en) | 2019-04-12 | 2020-04-14 | Plasmid system |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022530192A JP2022530192A (ja) | 2022-06-28 |
| JPWO2020208379A5 JPWO2020208379A5 (https=) | 2023-04-17 |
| JP2022530192A5 true JP2022530192A5 (https=) | 2023-04-17 |
| JP7562558B2 JP7562558B2 (ja) | 2024-10-07 |
Family
ID=70295566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560095A Active JP7562558B2 (ja) | 2019-04-12 | 2020-04-14 | プラスミドシステム |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220162642A1 (https=) |
| EP (1) | EP3953482A1 (https=) |
| JP (1) | JP7562558B2 (https=) |
| KR (1) | KR20220019669A (https=) |
| CN (1) | CN113891942A (https=) |
| AU (1) | AU2020272557A1 (https=) |
| BR (1) | BR112021020401A2 (https=) |
| CA (1) | CA3136545A1 (https=) |
| IL (2) | IL296544A (https=) |
| SG (1) | SG11202111149VA (https=) |
| WO (1) | WO2020208379A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202545984A (zh) | 2017-08-09 | 2025-12-01 | 美商生物化學醫療公司 | 核酸分子及其用途 |
| WO2020033863A1 (en) | 2018-08-09 | 2020-02-13 | Bioverativ Therapeutics Inc. | Nucleic acid molecules and uses thereof for non-viral gene therapy |
| EP3722434B1 (en) | 2019-04-12 | 2022-07-27 | Freeline Therapeutics Limited | Plasmid system |
| EP4051704A2 (en) | 2019-11-01 | 2022-09-07 | Freeline Therapeutics Limited | Factor viii construct |
| JP2024504365A (ja) * | 2021-01-22 | 2024-01-31 | バイオジェン・エムエイ・インコーポレイテッド | 組換えウイルスベクター力価を増加させる微小管不安定化剤添加剤 |
| AU2022227005B2 (en) * | 2021-02-26 | 2025-09-11 | Logicbio Therapeutics, Inc. | Manufacturing and use of recombinant aav vectors |
| EP4410971A4 (en) * | 2021-09-30 | 2025-06-04 | FUJIFILM Corporation | METHOD FOR PRODUCING AN ADENO-ASSOCIATED VIRUS, CELLS AND EXPRESSION VECTOR |
| GB202214328D0 (en) | 2022-09-29 | 2022-11-16 | Freeline Therapeutics Ltd | Method |
| WO2024160232A1 (zh) * | 2023-02-01 | 2024-08-08 | 纽福斯(苏州)生物科技有限公司 | 质粒包装系统及其应用 |
| CN118633572A (zh) * | 2023-03-06 | 2024-09-13 | 北京锦篮基因科技有限公司 | 神经元核内包涵体病小鼠模型构建方法及应用 |
| WO2024223931A1 (en) * | 2023-04-28 | 2024-10-31 | AstraZeneca Ireland Limited | Manufacturing and use of recombinant self-complementary aav vectors |
| TW202525832A (zh) | 2023-08-31 | 2025-07-01 | 美商戴諾治療公司 | 衣殼多肽及其使用方法(二) |
| WO2025083617A1 (en) * | 2023-10-18 | 2025-04-24 | Nanocell Therapeutics Holdings B.V. | Methods and compositions for nucleic construct delivery |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| TW202548023A (zh) | 2024-03-14 | 2025-12-16 | 美商雅菲納治療公司 | 用於生產重組腺相關病毒的質體系統 |
| EP4628576A1 (en) | 2024-04-07 | 2025-10-08 | Ascend Advanced Therapies GmbH | Microrna molecules for use in methods for improving recombinant aav production |
| WO2025238067A1 (en) | 2024-05-15 | 2025-11-20 | Ascend Advanced Therapies Gmbh | Novel vector system for aav production |
| WO2026064444A1 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026064428A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10044384A1 (de) | 2000-09-08 | 2002-04-18 | Medigene Ag | Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung |
| EP1419245A4 (en) * | 2001-07-13 | 2006-04-05 | Univ Iowa Res Found | ADENO-ASSOCIATED PSEUDOTYPE VIRUSES AND USES THEREOF |
| US20050080027A1 (en) | 2001-11-30 | 2005-04-14 | Markus Horer | Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
| ES2330826B1 (es) * | 2008-06-04 | 2010-07-26 | Proyecto De Biomedicina Cima, S.L. | Sistema para empaquetamiento de adenovirus de alta capacidad. |
| PL2403867T3 (pl) * | 2009-03-04 | 2019-12-31 | Deutsches Krebsforschungszentrum | Białko aktywujące składanie (aap) i jego zastosowanie do wytwarzania cząstek parwowirusa zasadniczo składających się z vp3 |
| ES2857773T5 (es) | 2011-08-24 | 2024-06-04 | Univ Leland Stanford Junior | Nuevas proteínas de la cápside de AAV para la transferencia de ácidos nucleicos |
| JP6348064B2 (ja) | 2011-11-22 | 2018-06-27 | ザ チルドレンズ ホスピタル オブ フィラデルフィア | 効率の高いトランスジーン送達のためのウイルスベクター |
| GB201420139D0 (en) | 2014-11-12 | 2014-12-24 | Ucl Business Plc | Factor IX gene therapy |
| GB201508026D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Capsid |
| US10385320B2 (en) | 2015-12-02 | 2019-08-20 | The Board Of Trustees Of The Leland Stanford Junior University | Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism |
| CN108048483B (zh) * | 2018-01-30 | 2021-02-02 | 中国疾病预防控制中心病毒病预防控制所 | 复制型重组腺病毒HAdV-5载体系统及其应用 |
-
2020
- 2020-04-14 AU AU2020272557A patent/AU2020272557A1/en active Pending
- 2020-04-14 JP JP2021560095A patent/JP7562558B2/ja active Active
- 2020-04-14 CN CN202080039790.8A patent/CN113891942A/zh active Pending
- 2020-04-14 EP EP20720111.2A patent/EP3953482A1/en active Pending
- 2020-04-14 WO PCT/GB2020/050947 patent/WO2020208379A1/en not_active Ceased
- 2020-04-14 CA CA3136545A patent/CA3136545A1/en active Pending
- 2020-04-14 US US17/602,941 patent/US20220162642A1/en not_active Abandoned
- 2020-04-14 KR KR1020217037076A patent/KR20220019669A/ko active Pending
- 2020-04-14 BR BR112021020401A patent/BR112021020401A2/pt unknown
- 2020-04-14 IL IL296544A patent/IL296544A/en unknown
- 2020-04-14 SG SG11202111149VA patent/SG11202111149VA/en unknown
-
2021
- 2021-10-07 IL IL287100A patent/IL287100A/en unknown